3rd BIOSTROKE MEETING
March 15 to 17, 2027
Hohenkammer Castle near Munich
WELCOME
We cordially invite you to join the 3rd BIOSTROKE Meeting, taking place at the historic Hohenkammer Castle near Munich from March 15 to 17, 2027.
BIOSTROKE offers a unique platform to advance biomarker science in stroke care and foster interdisciplinary collaboration between experts in stroke biomarker research, cardiovascular medicine, and neuroscience. Bringing together 120 participants, the meeting will facilitate in-depth scientific exchange on the most pressing, unsolved challenges in clinical decision-making with sessions across the stroke care continuum – from acute management to secondary prevention and long-term recovery. The program features talks by internationally recognized leaders, alongside presentations selected from submitted abstracts. The format prioritizes open discussion and informal interactions among scientists of all career levels.
Endorsement by the European Stroke Organization (ESO) and the European Society of Minimally Invasive Neurological Therapy (ESMINT) as well as CME/CPD accreditation are currently in process.
Participation requires registration* via this website (soon!).
We look forward to welcoming you in Munich in March 2027!
John McCabe, Johanna Ospel, Steffen Tiedt
REGISTRATION
Participation in the conference is limited to 120 attendees, with seats allocated on a first-come, first-served basis. We strongly encourage participation from PhD students, postdoctoral researchers, and scientists from underrepresented backgrounds. To support the next generation of researchers, 30 seats are reserved for early career investigators – including students, postdocs, and residents – at a reduced registration rate. Once these spots are filled, early career participants are welcome to register at the regular rate.
Registration includes:
- Access to all talks and poster sessions
- Accommodation (single room, 2 nights from March 15-17 2027 at Castle Hohenkammer, Munich)
- All meals and coffee breaks (not including extra alcoholic beverages)
This registration link is intended for academic participants and clinicians. Industry representatives who are interested in attending are kindly asked to contact the organizers directly.
SPEAKERS 2027
UTHealth & McGovern Medical School
UCLA
Population Health Research Institute & McMaster University
University of Edinburgh
University of Edinburgh
Massachusetts General Hospital, Harvard Medical School
University of Basel
UMC Utrecht
Uppsala University
Amsterdam UMC
KU Leuven
University of Glasgow
University of Manchester
Seoul National University Bundang Hospital & Seoul National University
Massachusetts General Hospital, Harvard Medical School
International Iberian Nanotechnology Laboratory
Lund University
Leiden University Medical Center
Inselspital, Bern University Hospital
ORGANIZING TEAM
University College
Dublin, Ireland
University of Calgary, Canada
Institute for Stroke &
Dementia Research, LMU Hospital Munich, Germany
PROGRAM
ABSTRACT SUBMISSION
Abstract Submission
Data Usage Notice
Your personal data will be treated confidentially by us and will only be used to contact you by e-mail, telephone and/or in writing as part of this contact. Your information will be adequately protected against access by third parties and collected, processed and used in accordance with the provisions of the Federal Data Protection Act. The provision of your personal data, in particular your data on your health, is voluntary. If necessary, your request will be forwarded to the responsible departments or persons within the Munich University Hospital (KUM). In this context, there is the possibility that non-medical staff of the clinic may gain knowledge of the information you have disclosed. This information will not be passed on or transmitted to third parties outside the clinic. Your data will be deleted no later than 3 months after your information has been evaluated or forwarded to the responsible office. You can revoke your consent to the earmarked processing and use of the data at any time in writing without giving reasons. Your stored data will then be deleted immediately within the framework of legal regulations. The relevant information about your request will be sent or forwarded to you in unencrypted form at the email address you provided, without providing any information about your health. This poses a risk under data protection law. We will only send requested patient and personal application documents to a reasonable extent by post if you have given your postal address. Please also note our general data protection declaration
VENUE
85411 Hohenkammer, Germany
Transport:
By car – arriving from North and South: From the South take the A9 in the direction of Ingolstadt/Nürnberg/Berlin; from the North take the A9 in the direction of Munich. Exit the A9 at junction Allershausen (67) and follow the signs to the left in the direction of Hohenkammer. Leave the roundabout at the second exit and follow the road, via Eglhausen, to Hohenkammer. At the end of the road, at Hohenkammer, turn right onto the B13 in the direction of Ingolstadt. Follow the main road past the church and then turn left onto Petershaser Strasse. You will reach Schlossstrasse on the right after 100 meters. Parking spaces are located directly after the bridge on your left.
By car – arriving from the Munich Airport: Leave the airport and get onto the A92 in the direction of Eching/Munich. Change over to the A9 in the direction of Ingolstadt/Nürnberg/Berlin at the motorway intersection Neufahrn. Exit the A9 at junction Allershausen and follow the above directions.
By taxi: The taxi ride from Munich Airport or Munich’s Central Station to the Hohenkammer Castle takes 30 and 50 min, respectively and costs 85-100 Euros. Visitors should take into consideration the transportation cost and traffic jam when planning their journey.
By train: Take the suburban rail, S2, from Munich’s Central Station in the direction of Ingolstadt and get off at Petershausen. The Hohenkammer Castle is just a few kilometers from Petershausen and easy to reach by taxi.
RESEARCH
Downloads:
- Research priorities for stroke biomarker development
- Reporting_datasets_prehospital_stroke
- Reporting_datasets_plaque_vulnerability
- Reporting_datasets_ischaemic_stroke_progression_recovery
- Reporting_datasets_ICH_progression
- Reporting_datasets_ICH_diagnosis
- Reporting_datasets_ICH_complications
- Reporting_datasets_atrial_cardiopathy
- Proposed_definitions_items
BIOSTROKE Meeting 2026
The 2nd BIOSTROKE meeting took place at Hohenkammer castle from February 23 to 25, 2026.
We thank all speakers, poster presenters, and participants for their contributions and the very fruitful, interesting discussions. We look forward to the strong science built on BIOSTROKE collaborations. Thanks to our funders (DFG, UoC, ISCBFM) and sponsors (Merck, CSL, Quanterix) for their support!
We look forward to welcoming you all again in 2027!
BIOSTROKE 2026 was endorsed by the European Stroke Organization (ESO) and the European Society of Minimally Invasive Neurological Therapy (ESMINT). CME/CPD accreditation is currently in process.
PROGRAM
PHOTOS FROM THE EVENT 2026















